Hikma Pharmaceutical reported 265.12B in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Almirall ALM:SM 1.92B 152.39M
Argen X Bv ARGX:BB 19.17B 4.02B
Artemis Alpha ATS:LN 13.9B 3B
AstraZeneca AZN:LN 16734.4B 1035.33B
Bayer BAYN:GR 55.72B 5.79B
Fresenius FRE:GR 16.28B 2.35B
Fresenius Medical Care FMS:US 14.65B 5.05B
Galapagos GLPG:NA 3.49B 209.75M
Genmab GEN:DC 151.04B 11B
GlaxoSmithKline GSK:LN 8976.58B 602.38B
Hikma Pharmaceutical HIK:LN 356.03B 157.67B
Lonza Group LONN:SW 37.9B 18.81B
Merck MRK:GR 20.81B 3.73B
Orion ORNBV:FH 6.01B 204.7M
Recordati REC:IM 8.68B 863.69M
Roche Holding ROG:VX 300.5B 1.25B
Sanofi SAN:FP 121.89B 4.99B
UCB UCB:BB 15.68B 3.83B